Transforming lives through advanced therapeutics

Pathway Bioventures invests in seed-stage precision therapeutics companies addressing important unmet medical needs. We back outstanding entrepreneurs on their mission to improve human health with breakthrough life sciences innovations.

learn more about us →

Revolutionary technology.
Remarkable teams.

We focus on finding and advancing technology at the cutting-edge of biology and engineering

Genetic medicine

Genetic medicine

Targeted therapies

Targeted therapies

learn more about our strategy →

Our investments

We have been proud to participate in financings for the following revolutionary companies:

Learn more about our investments →

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3B

FEATURED NEWS RELEASE →